In focus group interviews, married men with cancer reported better experiences for themselves and their caregivers with healthcare providers, compared with their single counterparts. Married men with ...

Recurrent prostate cancer patients with luminal B tumors may benefit from hormone therapy added to radiation following surgery.

The phase 2 EXTEND trial tested the progression-free survival (PFS) benefits of metastasis-directed therapy by solid tumor type.

Adjuvant radiotherapy improves locoregional failure-free survival, compared with observation, in patients with locally advanced MIBC.

Improving patients’ shared decision-making abilities in healthcare requires arming them with timely, accurate, patient-centered education.

Long-term trial findings support use of neoadjuvant chemotherapy in patients with high-risk localized upper tract urothelial carcinoma (UTUC).

Microcytic anemia, measured by red blood cell distribution width coefficient of variation, may be prognostic in type 2 diabetes.

In addition to the Medicaid price cuts, Pfizer also agreed to participate in a planned website called TrumpRx, which aims to allow people without insurance to buy certain drugs directly from the ...

Implantable biosensors and wearable technologies have the potential to enable continuous, real-time monitoring of kidney and ...

A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.